Navigation Links
Mark G. Watson Named Executive Director of Radiological Society of North America
Date:3/23/2009

OAK BROOK, Ill., March 23 /PRNewswire-USNewswire/ -- The Board of Directors of the Radiological Society of North America (RSNA) is pleased to announce that Mark G. Watson will become the Society's executive director on April 1, 2009. Watson comes to the position with nearly 20 years of experience working in key capacities at RSNA and has served as the Society's interim executive director since September 2008.

Assistant executive director for finance and administration at RSNA for the past 15 years, Watson was selected after a thorough candidate search by Korn/Ferry International in conjunction with RSNA's board of directors and executive director search committee.

"The board's selection of Mark Watson indicates not only its recognition of his history of distinguished service with the RSNA but also its confidence in his ability to provide the good counsel and effective leadership needed to realize the promise of RSNA's future," said Burton P. Drayer, M.D., chairman of the RSNA board of directors.

After graduating from Western Illinois University in Macomb with a bachelor's degree in business and accounting, Watson began his career in 1986 at the KPMG Peat Marwick accounting firm. In 1990, he was hired by RSNA as the director of finance, and two years later became the director of finance and business affairs. In 1994, he became assistant executive director of finance and administration.

During the next 15 years, Watson was responsible for all membership, financial and accounting activities of RSNA, including the development of long-term financial forecasting models that have proved critical to the board's strategic plans and decisions.

He has also been responsible for Society business and administration, including reviewing and negotiating all Society agreements and contracts with outside parties and developing and administering all personnel policies. He was involved in every detail of the development of the RSNA headquarters building, from site selection and financing through construction and move-in. During RSNA management of a number of radiology societies in the 1990s, Watson served as the executive director of the Radiation Research Society and the North American Hyperthermia Society, working closely with the governing boards and committees of these societies and overseeing their administration. In 2005, he was named director of the RSNA Research and Education Foundation.

His depth and breadth of knowledge of RSNA operations and his leadership skills made him the natural candidate for the position of interim executive director.

Colleagues and RSNA board members have long noted Watson's business and financial acumen, as well as his administrative skills.

"He has demonstrated integrity, sound judgment and the ability to make decisions at strategic and operational levels," Dr. Drayer said. "His understanding of and commitment to the RSNA mission, coupled with his genuine affinity for the volunteers and staff who carry it out on a day-to-day basis, have impressed all who have worked with him."

Watson was born in Iowa and has lived in the Chicago area since 1988. He and his wife of 23 years, Annamarie, have two children, Sarah and Matt.

RSNA is an association of more than 42,000 radiologists, radiation oncologists, medical physicists and related scientists committed to excellence in patient care through education and research. The Society is based in Oak Brook, Ill. (RSNA.org)


'/>"/>
SOURCE Radiological Society of North America (RSNA)
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
2. Watson Wyatt Identifies Major Benefit Trends During Open Enrollment Season
3. Texas Affiliates of Susan G. Komen for the Cure, Sen. Kirk Watson, Rep. Patrick Rose, Singer Kelly Willis, Breast Cancer Survivors and Activists Rally for Passage of Proposition 15
4. Watson Files FDA Application for Generic YAZ(R)
5. Watson Names Mark Durand Chief Financial Officer
6. Watson and Novartis Settle Lawsuit Over Exelon(R) Patent Litigation
7. Barr Subsidiary Sues Watson and Sandoz for SEASONALE(R) Patent Infringement
8. Watson Confirms Patent Litigation With Barr Related to Seasonale(R)
9. Watson Receives FDA Approval for Generic DuoNeb(R)
10. Watson to Distribute Alendronate Tablets
11. Medical Cost Increases to Accelerate Worldwide Over Next Five Years, Watson Wyatt Poll Finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... 10, 2016 , ... Early this week, Team Iconic at J. Walter Thompson ... as the first global confectionery brand sourced from 100% sustainable cocoa. , The Nestlé ... their product, through activities that focus on better farming, better lives and better cocoa. ...
(Date:2/10/2016)... ... ... As part of its ongoing series of aquatic therapy related webinars, HydroWorx ... dynamic expert and thoughtful presentation to give attendees a better sense of how to ... free to attend, but registration is required. , Rehabilitation of Offensive Lineman ...
(Date:2/10/2016)... ... February 10, 2016 , ... Emergency rooms provide emergency ... find. Unfortunately, this can leave patients with dental emergencies at risk of losing a ... offering emergency dental care. , Common dental emergencies include:, , ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... will bring together more than 200 of the country’s top healthcare executives to ... , “The true benefit of the Forum is the provider-centric perspective, experience, expertise ...
(Date:2/10/2016)... ... February 10, 2016 , ... AHRA: ... winner and inspirational speaker Jan Fox will serve as keynote speaker at the ... provide participants with tools to more effectively communicate with their own organizational staff ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... 10, 2016  Rich Pharmaceuticals, Inc. (OTC Markets: RCHA) ... reverse split of its issued and outstanding shares of ... Thursday, February 11, 2016. The Company,s common stock will ... 76303T308 and temporary ticker symbol "RCHAD". After 20 trading ... ticker symbol (RCHA).  --> ...
(Date:2/10/2016)... 2016  Oxis International Inc. (OTC/QB: OXIS) announced today ... as a "clinical trial triumph" after one of the ... cancer remission. Daniel Vallera , a ... Center. --> Daniel Vallera , a ... Center. --> An article on the ...
(Date:2/10/2016)... Feb. 10, 2016  The ALS Association, in partnership with ... Challenge to generate a biomarker to track TDP43 aggregation. The ... to a $1 million investment. --> ... that affects nerve cells in the brain and the spinal ... and control muscle movement, which often leads to total paralysis ...
Breaking Medicine Technology: